4.6 Article

Impact of diabetes on coronary severity and cardiovascular outcomes in patients with heterozygous familial hypercholesterolaemia

期刊

EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY
卷 28, 期 16, 页码 1807-1816

出版社

OXFORD UNIV PRESS
DOI: 10.1093/eurjpc/zwab042

关键词

Familial hypercholesterolaemia; Diabetes; Cardiovascular outcome

资金

  1. Capital Health Development Fund [201614035]
  2. Chinese Academy of Medical Sciences Innovation Fund for Medical Sciences [2016-I2M-1-011]
  3. Chinese Cardiovascular Association-V.G fund [2017-CCA-VG-017]

向作者/读者索取更多资源

The study found that type 2 diabetes is an independent predictor of coronary artery disease severity and hard cardiovascular endpoints in patients with familial hypercholesterolemia. Patients with type 2 diabetes were more likely to have coronary artery disease and had an increased risk of hard cardiovascular events.
Aims Type 2 diabetes mellitus (T2DM) is an independent risk factor for cardiovascular disease. However, the association between T2DM and coronary artery disease (CAD) in patients with heterozygous familial hypercholesterolaemia (HeFH) has not been thoroughly evaluated. Our study aimed to assess the effect of T2DM on CAD severity and hard cardiovascular endpoints in a HeFH cohort. Methods and results A total of 432 patients with HeFH with a molecular and/or clinical Dutch Lipid Clinic Network score >= 6 (definite and probable) were enrolled. Patients were divided into a T2DM group (n = 99) and a non-T2DM group (n = 333). The severity of coronary stenosis was assessed by the number of diseased vessels and Gensini, SYNTAX, and Jeopardy scores. Hard endpoints included a composite of non-fatal myocardial infarction, non-fatal stroke, and cardiac death. Cox regression and Kaplan-Meier analyses were used to evaluate the effect of T2DM on hard cardiovascular endpoints. The prevalence of CAD was higher in patients with T2DM compared with those without (96.0% vs. 77.5%, respectively; P < 0.001). Patients with T2DM demonstrated a greater number of diseased vessels (P = 0.029) and more severe coronary lesions with high Gensini, SYNTAX, and Jeopardy score tertiles (P = 0.031, P = 0.001, and P = 0.024, respectively). During a median of 3.75 years up to a maximum of 9 years of follow-up, hard endpoints occurred in 13 of 99 patients with T2DM and 16 of 333 without T2DM at baseline. Compared with patients without T2DM, patients with T2DM were at a significantly greater risk of hard endpoints [multivariate adjusted hazard ratio (HR) 2.32, 95% confidence interval (CI) 1.02-4.84; P = 0.025]. Additionally, patients with T2DM and good glucose control (HbA1c < 7.0%) were at a lower risk of hard endpoints compared with those with poor glucose control (HbA1c >= 7.0%, HR 0.08, 95% CI 0.01-0.56; P = 0.011). Conclusion We conclude that T2DM is an independent predictor of CAD severity when assessed by number of diseased vessels, Gensini, SYNTAX, Jeopardy scores, and hard cardiovascular endpoints, suggesting that T2DM could be further used for risk stratification of patients with HeFH.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据